# A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy Volunteers

> **NCT03647670** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 25 (actual)

## Conditions studied

- Phase 1

## Interventions

- **DRUG:** PF-04965842
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT03647670
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-03
- **Primary completion:** 2018-10-16
- **Final completion:** 2018-10-16
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03647670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03647670, "A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03647670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*